Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Sumida

Showing results (141-150 of 220) with videos related to

Pageof 22
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 6, 2016
Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitusYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 8, 2016
Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitusYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Human Pathology|February 12, 2017
Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinomaTomoko Kitaichi, Kohichiroh Yasui, Yasuyuki Gen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 16, 2011
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinomaKohichiroh Yasui, Etsuko Hashimoto, Yasuji Komorizono, et al.
Oncology Reports|February 18, 2016
Genome-wide DNA methylation analysis in hepatocellular carcinomaNobuhisa Yamada, Kohichiroh Yasui, Osamu Dohi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 19, 2016
Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progressionYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 13, 2024
Diagnostic performance of shear wave measurement in the detection of hepatic fibrosis: A multicenter prospective studyTakashi Kumada, Hidenori Toyoda, Sadanobu Ogawa, et al.
Gastroenterology|December 19, 2015
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient ElastographyKento Imajo, Takaomi Kessoku, Yasushi Honda, et al.
BMC Gastroenterology|January 7, 2012
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease populationYoshio Sumida, Masato Yoneda, Hideyuki Hyogo, et al.
European Journal of Gastroenterology & Hepatology|August 2, 2021
Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver diseaseToshifumi Tada, Toshiji Saibara, Masafumi Ono, et al.
Pageof 22

Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 6, 2016
Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitusYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 8, 2016
Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitusYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Human Pathology|February 12, 2017
Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinomaTomoko Kitaichi, Kohichiroh Yasui, Yasuyuki Gen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 16, 2011
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinomaKohichiroh Yasui, Etsuko Hashimoto, Yasuji Komorizono, et al.
Oncology Reports|February 18, 2016
Genome-wide DNA methylation analysis in hepatocellular carcinomaNobuhisa Yamada, Kohichiroh Yasui, Osamu Dohi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 19, 2016
Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progressionYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 13, 2024
Diagnostic performance of shear wave measurement in the detection of hepatic fibrosis: A multicenter prospective studyTakashi Kumada, Hidenori Toyoda, Sadanobu Ogawa, et al.
Gastroenterology|December 19, 2015
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient ElastographyKento Imajo, Takaomi Kessoku, Yasushi Honda, et al.
BMC Gastroenterology|January 7, 2012
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease populationYoshio Sumida, Masato Yoneda, Hideyuki Hyogo, et al.
European Journal of Gastroenterology & Hepatology|August 2, 2021
Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver diseaseToshifumi Tada, Toshiji Saibara, Masafumi Ono, et al.
Pageof 22